Personal details

Dr Lisa Philp
Postdoctoral Research Fellow
Faculty of Health,
School of Biomedical Sciences
IHBI Membership
Institute of Health Biomedical Innovation (IHBI),
IHBI Health Projects,
IHBI Biomedical Sciences - CDA
Discipline *
Biochemistry and Cell Biology, Other Medical and Health Sciences
+61 7 3443 7283
View location details (QUT staff and student access only)
Identifiers and profiles
ORCID iD Twitter LinkedIn

PhD (University of Adelaide)

Professional memberships
and associations

Current Committees:

2019-current        Chair of the Translational Research Institute Mentoring Committee

2019- current       Translational Research Institute Education and Training Committee

2019- current       Translational Research Institute Student Retreat Committee

2018-current        Translational Research Institute Biological Resource Facility User Group Committee, QUT representative

2018-current        Translational Research Institute Postdoc Network

2018-current        Movember Revolutionary Team Award “Adaptive Response to Targeting the Androgen Axis –A Strategic Offensive on Resistance” Executive Committee


Current Professional Memberships:

2019-current          Society for Endocrinology (international)

2018-current          American Association for Cancer Research (international)

2018-current          Translational Research Institute Mentoring Network

2018-current          Translational Research Institute Postdoc Network

2017-current           Queensland University of Technology Women in STEMM program

2014- current          The Endocrine Society (international)

2004- current          Golden Key International Honor Society (international)


adipokines, prostate cancer, endocrinology, preclinical modelling, drug development, obesity, metabolism

* Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008


Dr Philp is the leader of the Translational Adipokine Research group, within the Australian Prostate Cancer Research Centre – Queensland (APCRC-Q), based at the Translational Research Institute, Woolloongabba. As a trained physiologist and pharmacologist, she has over 13 years experience in animal modelling of human disease, and whole-body and molecular characterisation of phenotype and responsiveness to drug.

Since joining the APCRC-Q in 2014, Dr Philp’s work investigating the key role of adipokines in prostate cancer progression contributed to that of a large multi-disciplinary team of researchers at the APCRC-Q investigating the Adaptive Response to Targeting the Androgen Axis –A Strategic Offensive on Resistance in Prostate Cancer, that saw $6.25M funding awarded between 2014-2019 through a Movember Revolutionary Team Award. Her work demonstrating the importance of the adiponectin axis in prostate cancer progression, and the potent efficacy of targeting adiponectin signalling to halt tumour progression has seen her team most recently receive funding through a US Department of Defense Prostate Cancer Research Program – Idea Award of $US853896 (2020-2023). She was also recently awarded a 2020 Advance Queensland Industry Research Fellowship (AU$150,000) for her project “Preventing the respiratory failure causing COVID-19 mortality, potent new drugs targeting hyperinflammation”. Through this work, Dr Philp has strong industry linkages with two independent biotech/pharmaceutical companies based in the US, and collaborations with clinicians scientists and hospital partners.

Current projects are focused on the preclinical development of drugs, targeting adipokine signalling, in a quest to prevent disease, including prostate cancer progression to treatment resistance and acute respiratory distress syndrome.

These projects include:

1. Restoring the adiponectin axis as a novel prostate cancer therapy.

2. Targeting the dysregulation of leptin to combat treatment resistance in advanced prostate cancer.

3. Exploring the ying-yang of adipokines in human disease.

4. Preventing the respiratory failure causing COVID-19 mortality, potent new drugs targeting hyperinflammation.


This information has been contributed by Dr Lisa Philp.


For publications by this staff member, visit QUT ePrints, the University's research repository.

Research projects

Grants and projects (Category 1: Australian Competitive Grants only)

Adaptive Response to Targeting the Androgen Axis: A Strategic Offensive on Resistance (Stage 2)
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
Start year